Ishirguro Yukari 石黒由香利

… Alternative Names

Ishiguro Yukari 石黒由香利

ISHIGURO Yukari 石黒由香利

Less

Researcher Number	00423830
Affiliation (Current)	2025: 横浜市立大学, 附属市民総合医療センター, 特任助教
Affiliation (based on the past Project Information) *help	2019 – 2021: 横浜市立大学, 附属市民総合医療センター, 特任助教 2008 – 2011: Yokohama City University, 医学研究科, 特任助教 2006 – 2007: 横浜市立大学, 医学研究科, 博士研究員
Review Section/Research Field	Principal Investigator Otorhinolaryngology / Basic Section 56030:Urology-related Except Principal Investigator Otorhinolaryngology
Keywords	Principal Investigator EGFR阻害剤 / miRNAs / 去勢抵抗性前立腺癌 / miRNA / 前立腺癌 / 急性肺障害 / 間質性肺炎 / アンジオテンシンII / 分子標的治療 / 頭頸部癌 Except Principal Investigator アデノウイルス / 頭頸部癌 / テロメライシン

Investigation of the molecular mechanisms of castration resistant prostate cancer progressionPrincipal Investigator
- Principal Investigator
  
  Ishiguro Yukari
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Yokohama City University
Investigation to elucidate the mechanism of the onset of acute lung injury by the EGFR inhibitors, and the development of that suppression methodPrincipal Investigator
- Principal Investigator
  
  ISHIGURO Yukari
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Yokohama City University
アデノウイルスを用いたテロメラーゼプロモーター制御による頭頸部癌治療の開発
- Principal Investigator
  
  佃守
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Yokohama City University
Investigation to determine the cause of interstitial pneumonia by the EGFR inhibitors, and the development of that suppression methodPrincipal Investigator
- Principal Investigator
  
  ISHIGURO Yukari
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Yokohama City University
頭頸部癌におけるアンジオテンシンIIの機能解析とそのブロッカーによる抗腫瘍効果Principal Investigator
- Principal Investigator
  
  石黒由香利
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Young Scientists (Start-up)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Yokohama City University

All 2011 2010 2009 2008 2007

All Journal Article Presentation

[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.2011
- Author(s)
  Sakakibara A, Tsukuda M, Kondo N, Ishiguro Y, Kimura M, Fujita K, Takahashi H, Matsuda H
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 38(5) Pages: 589-99
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791619
[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.2011
- Author(s)
  Sakakibara A, Tsukuda M, Kondo N, Ishiguro Y, Kimura M, Fujita K, Takahashi H, Matsuda H
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 38(5) Pages: 589-599
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592201
[Journal Article] Antitumor effects of lapatinib(GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma2011
- Author(s)
  Kondo N, Tsukuda M, Ishiguro Y, Kimura M, Fujita K, Sakakibara A, Takahashi H, Toth G, Matsuda H.
- Journal Title
  
  Oncol Rep
  
  Volume: 23(4) Pages: 957-63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791619
[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines2011
- Author(s)
  Sakakibara A, Tsukuda M, Kondo N, Ishiguro Y, Kimura M, Fujita K, Takahashi H, Matsuda H
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 38(5) Issue: 5 Pages: 589-599
- DOI
  10.1016/j.anl.2011.01.018
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592201
[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines2011
- Author(s)
  Sakakibara A, Tsukuda M, Kondo N, Ishiguro Y, Kimura M, Fujita K, Takahashi H, Matsuda H.
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 38(5) Pages: 589-99
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791619
[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR anf HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2010
- Author(s)
  Kondo N, Tsukuda M, Ishiguro Y, Kimura M, Fujita K, Sakakibara A, Takahashi H, Toth G, Matsuda H.
- Journal Title
  
  Oncol Rep. 23(4)
  
  Pages: 957-963
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2010
- Author(s)
  Kondo N, Tsukuda M, Ishiguro Y, Kimura M, Fujita K, Sakakibara A, Takahashi H, Toth G, Matsuda H
- Journal Title
  
  Oncol Rep.
  
  Volume: 23(4) Pages: 957-63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791619
[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2009
- Author(s)
  Kondo N, Tsukuda M, Ishiguro Y, Kimura M, Fujita K, Sakakibara A, Takahashi H, Toth G, Matsuda H
- Journal Title
  
  Oncol Rep. 23(4)
  
  Pages: 957-63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.2009
- Author(s)
  Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K, Ozono S, Maehata Y, Taguchi T, Imagawa-Ishiguro Y, Tsukuda M, Kubota E, Hata R.
- Journal Title
  
  Cancer Sci. 100(1)
  
  Pages: 2202-2209
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] aPKClambd/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.2009
- Author(s)
  Ishiguro H, Akimoto K, Nagashima Y, Kojima Y, Sasaki T, Ishiguro-Imagawa Y, Nakaigawa N, Ohno S, Kubota Y, Uemura H.
- Journal Title
  
  Proc Natl Acad Sci USA. 106(38)
  
  Pages: 16369-16374
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.2009
- Author(s)
  Ishiguro H, Akimoto K, Nagashima Y, Kojima Y, Sasaki T, Ishiguro-Imagawa Y, Nakaigawa N, Ohno S, Kubota Y, Uemura H
- Journal Title
  
  Proc Natl Acad Sci U S A 106(38)
  
  Pages: 16369-74
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.2009
- Author(s)
  Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K, Ozono S, Maehata Y, Taguchi T, Imagawa-Ishiguro Y, Tsukuda M, Kubota E, Hata R
- Journal Title
  
  Cancer Sci. 100(11)
  
  Pages: 2202-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.2008
- Author(s)
  Taguchi T, Tsukuda M, Imagawa-Ishiguro Y, Kato Y, Sano D
- Journal Title
  
  Oncol Rep. 19(1)
  
  Pages: 65-71
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791210
[Journal Article] Angiotensin II induces oxidative stress in prostate cancer.2008
- Author(s)
  Uemura H, Ishiguro H, IshiguroY, Hoshino K, Takahashi S, Kubota Y.
- Journal Title
  
  Mol Cancer Res. 6(2)
  
  Pages: 250-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18890156
[Journal Article] Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.2007
- Author(s)
  Ishiguro H
- Journal Title
  
  Prostate (in press)
- Data Source
  KAKENHI-PROJECT-18890156
[Presentation] Cancer cells treated with EGFR blocker induce fibrosis of normal human fibroblast cells.2010
- Author(s)
  石黒由香利
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22791619
[Presentation] Cancer cells treated with EGFR blocker induce fibrosis of normal human fibroblast cells2010
- Author(s)
  石黒由香利, 石黒斉, 佃守
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場(大阪)
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22791619
[Presentation] 頭頸扁平上皮癌において、GefitinibはBRAK/CXCL14の発現を介して抗腫瘍効果を示す2009
- Author(s)
  加藤靖正, 田口享秀, 石黒由香利, 佃守
- Organizer
  第22回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-20791210
[Presentation] ケモカインBRAK/CXCL14をマーカー分子とした頭頸部扁平上皮癌への新たな併用療法の試み2009
- Author(s)
  小澤重幸, 加藤靖正, 伊藤慎, 小森令賀, 椎木直人, 槻木恵一, 前畑洋次郎, 田口享秀, 石黒(今川)由香利, 佃守, 畑隆一郎, 久保田英朗
- Organizer
  第19回日本口腔粘膜学会総会・学術集会
- Place of Presentation
  葉山町
- Data Source
  KAKENHI-PROJECT-20791210
[Presentation] The role of aPKC lambda in prostate cancer progression.2008
- Author(s)
  石黒斉, 秋本和憲, 長嶋洋治, 小島康幸, 石黒由香利, 佐々木毅, 上村博司, 大野茂男, 窪田吉信
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-20791210
[Presentation] Fibrosis of normal lung cells is caused by some particular factors from cancer cells treated with EGFR-TKI.2008
- Author(s)
  石黒由香利, 石黒斉, 佃守
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-20791210
[Presentation] Fibrosis of normal lung cells is caused by some particular factors from cancer cells treated with EGFR-TKI2008
- Author(s)
  石黒由香利
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20791210

1. 佃守 (70142370)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. 堀内長一 (40295499)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 石黒斉 (00381666)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 上村博司 (50244439)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Ishirguro Yukari 石黒 由香利

Ishiguro Yukari 石黒 由香利

ISHIGURO Yukari 石黒 由香利

Research Projects

Research Products

Co-Researchers

Investigation of the molecular mechanisms of castration resistant prostate cancer progressionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation to elucidate the mechanism of the onset of acute lung injury by the EGFR inhibitors, and the development of that suppression methodPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

アデノウイルスを用いたテロメラーゼプロモーター制御による頭頸部癌治療の開発

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation to determine the cause of interstitial pneumonia by the EGFR inhibitors, and the development of that suppression methodPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

頭頸部癌におけるアンジオテンシンIIの機能解析とそのブロッカーによる抗腫瘍効果Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.2011

Author(s)

Journal Title

Data Source

[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.2011

Author(s)

Journal Title

Data Source

[Journal Article] Antitumor effects of lapatinib(GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma2011

Author(s)

Journal Title

Data Source

[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines2011

Author(s)

Journal Title

Data Source

[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR anf HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2010

Author(s)

Journal Title

Data Source

[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2010

Author(s)

Journal Title

Data Source

[Journal Article] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.2009

Author(s)

Journal Title

Data Source

[Journal Article] Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.2009

Author(s)

Journal Title

Data Source

[Journal Article] aPKClambd/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.2009

Author(s)

Journal Title

Data Source

[Journal Article] aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.2009

Author(s)

Journal Title

Ishirguro Yukari 石黒由香利

Ishiguro Yukari 石黒由香利

ISHIGURO Yukari 石黒由香利